Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 17, 2022

View Archived Issues

Novel ER modulator daidzein analogues confer antitumoral effect in prostate cancer

Machine learning approach speeds resistance identification

BeiGene discloses non-receptor tyrosine-protein kinase TYK2 inhibitors

New GLP-1 receptor agonists identified at Guangzhou Henovcom Bioscience

Celgene presents new cereblon-binding PROTACs

New glucocorticoid receptor antagonists discovered at Corcept Therapeutics

Viral replication inhibitors patented by Gilead

New 3,5-diaryl-substituted pyrazoles inhibit prostate cancer cell growth

Targeting IP3R-mediated Ca2+ homeostasis in adipocytes as strategy against metabolic disease

AstraZeneca and Scorpion collaborate on therapeutics against transcription factors for cancer

Intranasal influenza-based boost vaccination for preventing SARS-CoV-2 infection

Vir expands partnership with Gates Foundation in HIV and malaria

Preclinical data confirm anticancer activity of two lead compounds in Captor's CT-01 program in HCC

Novel genes identified with risk of obsessive-compulsive disorder

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...